ADORA2A and chronic myelogenous leukemia, BCR-ABL1 positive: In the present study, we found that ADORA2A-AS1 expression was upregulated in CML samples and cells, and knockdown of ADORA2A-AS1 could inhibit cell proliferation and induce cell apoptosis and cell cycle arrest in CML cells.